author-photo

Mark A. Exley

Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Harvard University

160

Papers

9724

Citations

Citation Trend

Filter By

Papers (119) Sort By

Journal Conference Others

Abstract LB181: Autologous glioblastoma tumor cells treated with an antisense oligonucleotide against insulin-like growth factor type 1 receptor protect mice against GL261 tumor challenge

2021 Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
218 Autologous glioblastoma tumor cells and an antisense oligonucleotide against insulin-like growth factor type 1 receptor protect against tumor challenge and generate T cell anti-tumor responses

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A nano-engager for iNKT cells in cancer

2020
Show All
- Source
- Cite
- Save
Citations (0)
Evaluation of the frequency of invariant natural killer T (iNKT) cells in nasal polyps

2019 Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin

2019 Nature Immunology
Show All
- Source
- Cite
- Save
Citations (18)
iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome

2019 Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (2)
Positive & negative roles of innate effector cells in controlling cancer progression

2018 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (15)
Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy

2018 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (66)
IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells

2018 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (20)